Caprion’s leading and proprietary proteomics discovery technologies - CellCarta® - enable the discovery of novel targets for therapeutics development and the identification of novel protein biomarkers that can significantly reduce risk and enhance clinical development productivity and decision making in Pharmaceutical research.

Caprion Proteomics wins Frost & Sullivan Award

Details of the award in PDF

U.S. National Institutes of Health (NIH) choose Caprion's distinctive, quantitative protein profiling technologies to analyze pathogen and host proteins involved during Brucella (a potential bioterrorism agent) infection. 

Click here for details.

Ranks Caprion as "fast 15" within life sciences companies. (more...)

News

July 11, 2008

Drug Discovery & Development magizine article - July 01, 2008 "Genes lead to proteins, yes, but there's something more beyond translation. You need the protein sequence."

January 15, 2008

Caprion article in Genetic Engineering & biotechnology News: "Capitalizing on Biomarker Discovery Work" January 15th 2008 issue (Volume 28, Number 2)

›› archive

Events

September 29 - October 1, 2008

CHI: Biomarker Discovery Summit; Dr. Joanna Hunter (presenting), Didier Jean-Francois attending (booth)

Philadelphia, USA

November 17 - 19, 2008

BIO Europe; Didier Jean-Francois attending

Manheim/Heidelberg, Germany

›› archive